Archive

Tag Archives: Personal

IMG_5491 (1)

Above: Manchester, UK

For those who picked up on the first post I hope that you took the time to go on to Sarah Knowles second and third posts on the topic. If not, then here are the links…

‘Science vs The Gap’

https://datapatientaction.wordpress.com/2018/01/24/three-cheers-for-implementation-science-2-science-vs-the-gap/

and, ‘You Make Me Want to be a Better Researcher’

https://datapatientaction.wordpress.com/2018/01/24/three-cheers-for-implementation-science-3-you-make-me-want-to-be-a-better-researcher/

Worth a read. I was lucky to meet Sarah and other members of the Greater Manchester NIHR CLAHRC on a visit last year. Sarah is a proper implementation scientist – I am not!

These posts are good for the uninitiated (i.e. those people who are thinking ‘what is implementation science anyway?’) and those wondering why I’m posting about it.

My favourite is Cheer #3 – probably the least well recognised and understood but for me the most important because it emphasises the two-way connection that should exist between clinical research and implementation science. It’s what takes implementation science from being an academic curiosity to a ‘thing’ that clinician scientists benefit from understanding and engaging with.

 

The last couple of years have been busy and seen change. In the true spirit of ‘generalism’ I now have three jobs.

My practice,

My public practice, and

A university position…

The latter, as the Clinical Director, of The Australian Centre for Health Service Innovation (AusHSI) is perhaps the biggest diversion from my work as a cardiologist but sits squarely within the direction of my research work and has offered fascinating opportunities I had never expected. Read more about AusHSI here, and visit the AusHSI Blog here.

In addition to this has been growing responsibilities with the Cardiac Society (CSANZ) and editorial duties at Heart, Lung and Circulation.

Hence the difficulty finding time for the blog…

I’ll be presenting a moderated poster in session 1302M: High sensitivity troponins: New insights at the #ACC13 meeting this morning. The paper compares the diagnostic accuracy of two high sensitivity assays for clinical end points in a large cohort of ED chest pain patients. If you want a copy of the poster then I should be able to direct you haw to get a reprint if you contact me either through the blog or twitter (@LastCardiology)

There are important presentations from a number of other prominent research groups working in the area including Christian Mueller’s group and the ROMICAT team.

The posters are going to be moderated by Harvey White and Kristin Newby so there should be some lively discussion… me? nervous? nahhhh!

It seems I only ever get time to really work on my blog when I get away to a conference.

So here I am in wonderful San Francisco ready to soak up all that the American College of Cardiology meeting has to offer in 2013. The theme is ‘Discovery to Delivery’ although many of the subjects of the ‘late breaking’ sessions involve decidedly old drugs in refined applications – think tenecteplase in PE, viagra in diastolic heart failure, digoxin in the elderly…

Non-pharma interventions will feature heavily with more on TAVI, atrial appendage occluders and another ‘old’ idea; off-pump bypass surgery.

You can find a good summary of the things that might attract attention here, courtesy of the heart.org.

We’re here to present some new data on high sensitivity troponin in a session of moderated posters on Monday, but I will post separately on that. For starters the abstracts are all now online and you can check out the session here.

The plan is to try and do a daily post at least with lots of tweeting on the #ACC13 hashtag, so we’ll see how it goes. It’s going to be a busy few days.

Dear Will,

Thank you for registering to attend ACC.13, March 9-11 in San Francisco.

Our records indicate that you signed up to participate in the 5K CardioSource Fun Run event, scheduled for Monday, March 11, 2013. We are writing to inform you that this event has been cancelled due to liability issues caused by the change in Daylight Savings Time while we are in San Francisco which has impacted our ability to effectively manage the run.  We apologize for any inconvenience, and look forward to welcoming you to ACC.13.

Sincerely,

The ACC Registration Team

When I started blogging about a year ago I made the un-bold decision that I would keep by blog and the associate twitter account anonymous. It wasn’t a real attempt at anonymity and in fact has become a bit of a joke. The identity of @LastCardiology is one of the worst kept secrets amongst my peers!

That being said, the decision not to link my name to the blog did have some basis.

Firstly, I was at the time responsible for convening a large medical scientific meeting – probably the largest in the country in terms of attendance and budget. The meeting, its brand and its outcome – whilst a matter of great interest to me – really belong to the learned society of which I am a member. Consequently, whilst wanting to help promote the merits of the meeting I had no desire to use that as a cheap source of publicity for my own online activity and even less desire to see something that I might write have a negative impact on the outcome of the meeting.

Secondly, I was at the time somewhat taken by the multitude of blogposts on the risks of social media to the practice medical professionals and being new to the game, it was not my desire to run the gauntlet of this potentially perilous activity.

So almost a year on, with the meeting successfully out of the way and a considerably better feel for the risks and benefits of ‘the social media’ I was just about to lower my guard and formally blow the (laughably transparent) veil of anonymity away from my blog.

And then this…

‘Preliminary Consultation Paper on Social Media Policy’ from the Australian Health Practitioner Regulation Authority (AHPRA).

Above all, as a researcher as well as a clinician, I had begun to feel that the the social media had a compelling role in the future dissemination, promotion and integration of research activity. And there’s the rub. If as a clinician/researcher I am ‘out there’ promoting the merits of the clinical research of our group, cross blogging positive editorial comment, extolling the virtue of translating the findings of our work into daily clinical practice – will I fall foul of the law as interpreted by AHPRA?

After all…

‘The definition of advertising under the Advertising Guidelines is broad…’

and…

A person advertising a regulated health service may contravene the National Law even if they are not themselves a registered health practitioner. As a result, a person may be found to have ‘advertised’ a health service even though they did not intend to advertise or promote their health service.’

Above all,

‘Testimonials, or comments that may amount to testimonials, made on social media sites by patients or other people may contravene the National Law and expose the registered health practitioner and/or the holder of the social networking account to liability.’

To me, the document appears uniformly negative, short-sighted, misguided and even somewhat paranoid. The sort of thing that one might have read in the tabloid press concerning the perils of the ‘information super highway’… about 15 years ago.

I’d be most interested others comments and advice on this matter either here or through my blog at https://thelastgeneralcardiologist.wordpress.com but please be careful not to saying anything positive about me!

Thanks.

@LastCardiology

For additional commentary see

http://blogs.crikey.com.au/croakey/?p=8923 and http://blogs.crikey.com.au/croakey/?p=8939